Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Arm Tremor in Dystonia
NCT06411028Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2025
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Dystonic tremor syndrome (DT), sponsored by Radboud University Medical Center. Started Jan 2025; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Dystonic tremor syndrome (DT)
Beyond the preview
Go deeper on NCT06411028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411028.